1 / 7

Pharmaceutical Intermediates Market Poised to Expand at 4.4 % CAGR During 2019 - 2029

Pharmaceutical Intermediates Market Poised to Expand at 4.4 % CAGR During 2019 - 2029

ankush321
Download Presentation

Pharmaceutical Intermediates Market Poised to Expand at 4.4 % CAGR During 2019 - 2029

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Pharmaceutical Intermediates Market to Incur High Value Growth at 4.4 % CAGR During 2019 - 2029 www.futuremarketinsights.com I @futuremarketins I /company/future-market-insights © 2019 Future Market Insights, All Rights Reserved March 2020 Report Id : REP-GB-4515 Published On : 26 April, 2019 Category : Healthcare, Pharmaceuticals & Medical Devices

  2. AboutFuture Market Insights Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends. We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC. Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and Retail. We have a global presence with delivery centers across India specializing in providing global research reports and country research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for our client. Research Capabilities Sector Coverage • Customized Research • Syndicated Research • Investment Research • Social Media Research • Automotive and Transportation • Electronics, Semiconductor, and ICT • Retail and Consumer Products • Industrial Automation and Equipment • Chemicals & Materials • Food and Beverages • Services and Utilities • Energy, Mining, Oil, and Gas Customized Research Syndicated Research Investment Research Social Media Research Subscription Information For detailed subscription information please contact Hari. T (Sr. Manager - Global Business Development) T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268 Email: hari.t@futuremarketinsights.com

  3. Research Methodology (1/2) Research & Intelligence Data Collection Actionable Insights Data Filter & Analysis Business Solution 1 Market profiling 2 Formulating discussion guide • Identifying key opinion leaders • Questionnaire design • In-depth interviews • Coverage across value chain 3 A Developing list of respondents • Key industry experts • Channel study • Developments • Market dynamics • Products • Conclusions Primary Research 4 SOLUTION Data collection • Market participants • Key strengths • Product portfolio • Mapping as per value chain • Key focus segments B 5 Desk Research Data validation 6 C Data analysis Primary Research # • Secondary Research # • Paid Publications# Company Analysis • Linkedin • Zoominfo • Salesforce • Avention • Company websites • Company annual reports • White papers • Financial reports • Factiva • GBI • Genios • Meltwater 7 Insights Systematic Research Approach # includes sources of databases

  4. Pharmaceutical Intermediates Market Global sales of pharmaceutical intermediates closed in on US$ 26 billion 2018, which is likely to see modest Y-o-Y growth in 2019, by an estimated 3.6% rate. More than 70% of the pharmaceutical intermediates consumed, were generic. A moderate demand growth outlook has been projected for branded pharmaceutical intermediates. Prominently driven by high sales of chiral intermediates, bulk drug intermediates will continue to account for over 3/5th of overall sales, followed by chemical intermediates. The report highlights pivotal role of CROs (contract research organizations) and CMOs (contract manufacturing organizations) in shaping the pharmaceutical intermediates market, as they collectively contribute more than 60% to the market value. Pharma and biotech companies are also likely to develop as key end users of pharmaceutical intermediates in the near future. Application in Analgesics Account for a Third of Global Revenue Increasing prevalence of the chronic diseases, coupled with the improved rate of early diagnosis, is heavily contributing to the towering drug demand. The report opines that prevalence rate of CVDs (cardiovascular diseases) and diabetes will particularly bolster pharmaceutical intermediates consumption. Over 1/3rd of the pharmaceutical intermediates market revenues is accounted by application in analgesics, followed by cardiovascular drugs and oral antidiabetic drugs, as reported by the study. Moreover, the increasing rate of seeking treatment is also likely to boost the demand for drugs. According to the report, global pandemics, such as H1N1, Ebola, and others are also accounting for fostering drug demand – thereby pushing consumption of a wide range of APIs and pharmaceutical intermediates.

  5. Pharmaceutical Intermediates Market Manufacturing Companies to Strategize on Increasing Drug Approvals A couple of years ago, the Center for drug evaluation and research (CDER) approved more than 45 novel drugs, compared to 22 in 2016. The average novel drug approval each year, is around 31 and, and thus FMI’s analysis finds that the year 2017 witnessed a significant rise in the number of drug approvals. With the number of drug approvals on a constant rise, it is highly likely that the demand for pharmaceutical raw materials such as pharmaceutical intermediates and APIs will also witness gains in the years to come. To cater to billowing demand in drug formulations, a number of players prominently active in the global pharmaceutical intermediates landscape are maintaining focus on expanding production capacity. Merck KGaA, for an instance, has announced production capacity expansion in Aubonne, Switzerland. The new production facility is supposed to be fully functional by the end of 2023, as reported. The production capacity will be enhanced by over 50% of the existing. Pharmaceutical intermediates manufacturers seeking cGMP (Current Good Manufacturing Practice regulations) approval from various western regulatory bodies. Key manufacturers of pharmaceutical intermediates, particularly those based in the East and South Asian regions, are focused on their efforts in gaining FDA or EMA (European Medicine Agency) regulatory approvals for their manufacturing plants. FMI’s research marks that the production costs associated with pharmaceutical intermediates, APIs, and final drug formulations is around 50-60% less when based in emerging Asian markets, compared to that in North America and Europe. This cost benefit according to the report will continue to attract foreign investments from pharmaceutical and biopharmaceutical companies based in overseas. On the other side, leading exporters of pharmaceutical intermediates are focusing on blending the lower production costs and high quality.

  6. Pharmaceutical Intermediates Market The report tracks some of the key companies operating in the Pharmaceutical Intermediates market, including Chiracon GmbH, Aceto Corporation, Midas Pharma GmbH, BASF SE, Codexis, Inc., A.R. Life Sciences Private Limited, Dishman Group, ZCL Chemicals Ltd., Pfizer, Inc., ArkemaInc and Cambrex Corporation among others. Source of Press-Release : https://www.globenewswire.com/news-release/2019/04/29/1811232/0/en/Pharmaceutical-Intermediates-Market-Estimated-to-Expand-at-a-Robust-CAGR-of-4-4-CAGR-over-2029-Future-Market-Insights.html About Us Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights and an aerial view of the competitive framework and future market trends. Contact Us Mr. Abhishek BudholiyaFuture Market Insights616 Corporate Way, Suite 2-9018,Valley Cottage, NY 10989,United StatesT: +1-347-918-3531F: +1-845-579-5705T (UK): + 44 (0) 20 7692 8790Sales:sales@futuremarketinsights.com

  7. To know more about us, please visit our website: www.futuremarketinsights.com For sales queries or new topics email us on: sales@futuremarketinsights.com For media queries, contact the press office at press@futuremarketinsights.com For other queries contact:Hari. T (Sr. Manager - Global Business Development) Future Market Insights: 3rd Floor,207 Regent Street, London W1B 3HH T: +44 20 7692 8790 | D: +44 20 3287 4268 Email: hari.t@futuremarketinsights.com Thank You Future Market Insights Global & Consulting Private Limited (FMI)

More Related